About Exelead
Exelead is a company based in Indianapolis (United States) founded in 2016 was acquired by Merck in January 2022.. Exelead offers products and services including Lipid Nanoparticle CDMO and mRNA Development and Manufacturing. Exelead operates in a competitive market with competitors including Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others.
- Headquarter Indianapolis, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Exelead
Exelead offers a comprehensive portfolio of products and services, including Lipid Nanoparticle CDMO and mRNA Development and Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for developing and manufacturing lipid nanoparticles for drug delivery
Provides synthesis, purification, and formulation for mRNA products
Unlock access to complete
Unlock access to complete
Funding Insights of Exelead
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Exelead
Exelead has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Merck is engaged in science and technology solutions globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Exelead
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Exelead
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exelead Comparisons
Competitors of Exelead
Exelead operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Gland Pharma, August Bioservices, ApiJect and Vetter Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| domain | founded_year | HQ Location |
Diversified research services for clinical solutions are offered.
|
|
| domain | founded_year | HQ Location |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| domain | founded_year | HQ Location |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| domain | founded_year | HQ Location |
Injectable drug products are manufactured by this biopharma CDMO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exelead
Frequently Asked Questions about Exelead
When was Exelead founded?
Exelead was founded in 2016.
Where is Exelead located?
Exelead is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
What does Exelead do?
Exelead, a wholly owned subsidiary of Leadiant Biosciences, is a contract manufacturer of liquid injectables and specializes in the development and manufacturing of complex liposomal and pegylated formulations. The company has capabilities to manufacture for both clinical and commercial applications. Their clientele includes companies ranging from small, venture startups to medium size companies. The company is capable of handling small batches and formulations which are meant for rare disease and small populations. Their clientele includes Teva, Shire (Exelead is the CMO for Oncaspar), Horizon Pharma and Aradigm. The company also has an in-house portfolio which includes Adagen (a pegademase bovine injection), DepoCyt (cytarabine liposome injection), and Abelcet (amphotericin B lipid complex injection).
Who are the top competitors of Exelead?
Exelead's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
What products or services does Exelead offer?
Exelead offers Lipid Nanoparticle CDMO and mRNA Development and Manufacturing.
Who are Exelead's investors?
Exelead has 1 investor. Key investors include Merck.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.